Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$2,336.7M | 4.7 | (4,363.8%) | (4,372.6%) | (3,313.1%) | (26.8%) | (30.1%) | 65.9% | 0.0% | |
$124.8B | 4.8 | (15.0%) | (22.6%) | (11.5%) | (3.3%) | (5.5%) | 0.1% | 1.3% | |
$77.0B | 6.0 | 25.7% | 18.1% | 25.3% | 13.7% | 10.3% | 1.4% | 4.1% | |
$34.4B | 4.2 | (41.3%) | N/A | (24.0%) | (4.8%) | (8.5%) | 2.2% | 0.0% | |
$30.7B | 3.9 | (7.2%) | (14.8%) | (4.0%) | (559.4%) | (2.6%) | 2.4% | 0.0% | |
$24.0B | 4.7 | (37.8%) | (45.6%) | (6.7%) | (3.5%) | (6.5%) | 0.8% | 0.0% | |
$14.5B | 5.5 | 14.5% | 9.6% | 37.0% | 12.9% | 6.4% | (2.8%) | 3.6% | |
$13.8B | 7.3 | 65.4% | 57.7% | 68.4% | 19.1% | 16.0% | (5.1%) | 7.3% | |
$13.4B | 6.2 | 11.0% | 3.5% | 15.1% | 7.7% | 5.5% | 1.0% | 0.5% | |
$13.3B | 4.5 | (3,335.4%) | (3,343.2%) | (2,216.2%) | (53.5%) | (51.1%) | 3.6% | 0.0% | |
$1,846.9M | 4.3 | (43.2%) | (47.6%) | (43.3%) | (25.3%) | (27.4%) | 1.2% | 0.0% |
The Longboard Pharmaceuticals, Inc. (LBPH) ROIC is (4,363.8%), compared to the industry median of ((127.6%)) and the 5-year historical average of (12,555.5%).
The Longboard Pharmaceuticals, Inc. (LBPH) ROIC minus WACC is (4,372.6%), compared to the industry median of ((132.7%)) and the 5-year historical average of (12,563.6%).
The Longboard Pharmaceuticals, Inc. (LBPH) ROE is (26.8%), compared to the industry median of ((50.7%)) and the 5-year historical average of (19.0%).
The Longboard Pharmaceuticals, Inc. (LBPH) ROCE is (30.1%), compared to the industry median of ((51.1%)) and the 5-year historical average of (36.6%).